Replies to post #203344 on Cytodyn Inc (CYDY)

[misiu143]

JPG77 , you are right , Brazil is progressing , according to CTMedic post , below , there are 51 Centers open , now enrolling ..
Company going BK will not be able to do that..

With 51 centers enrollment should be fast ,

For moderate /severe , we need total 612 patients and 245 for interim results.
Every patient admitted to the hospital is moderate/severe , it should go fast with 51 Centers !!
About 5 patients from every center to have interim results..

In our critical we need total 316 patients and plan was to have 51 patients for interim , but even if they plan to have now the initial 127 , this should really go fast..about 3 patients per center.

And 27 days after the last patient , study will be finish..

So now with this new wave , and new centers added , things really should progress fast..

And if the results will be as good as many of us think , 2-3 months from now we may finally have EUAs in few countries...



Below CTMedic post.
------------------------------------------------

Currently 51 trial sites listed on plataformabrasil.saude.gov.br for the Cytodyn moderate Leronlimab trial.7 of these are new or updated entries since January 4 (entries highlighted in yellow).

I'll offer that this indicates that these trials are ongoing.

The most recent entry added or updated is for Hospital Otoclinica in Fortoleza (Wednesday, Feb 9).
Fortoleza is (thanks to Wikipedia) the capital of Ceara in the Northeast of Brazil.

Cases are declining in Sao Paulo, but apparently still increasing in the northeast, northwest and far south of Brazil.

[The Dark KnaDDir]

All hopium. When has the company ever come through and achieved any of its objectives? How's India working out with McLeods? Yeah, those Brazil trials sure are filing fast. I'll stick with the auditor and his going concern warning about this company on the verge of bankruptcy, thanks.